This research project will work with stroke survivors and their families. In year one, we will design a healthy living programme for stroke survivors and their families. The programme will provide information, education and support. It will help people to learn how to manage their own lifestyle risk factors.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC). Published today, the AMRC have launched a new booklet outling highlighting how vital health information is to enable researchers to prevent, diagnose and treat disease and improve care.
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
This project aims to develop and test a repetitive functional task practice (RFTP) therapy programme. Research physiotherapists will develop the programme in conjunction with stroke unit staff and patients.
Early Supported Discharge (ESD) is the discharge of a stroke patient from hospital to their own home, co-ordinated by a team of therapists, nurses and a doctor. A number of ESD services have been set up across England. Do these services offer the same benefits to patients as those identified in clinical trials?
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
This guide provides information about why someone might not survive a stroke, and the emotional impact on family and carers. Plus a list of useful resources to help you with practical issues such as how to register a death, finding professional counselling services, and support for bereaved children.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Thousands of lives a year could be changed thanks to a pilot research study by Imperial College which involves injecting a patient's stem cells into their brain.
Funded by the Wellcome Trust, researchers at Newcastle University have shown that, in monkeys, it is possible to restore hand and arm movement lost through brain damage.